All News #Library
Biotech
Trading Statement Q1-2025: A Landmark Deal for GUBamy
09 May 2025 //
ACCESSWIRE
AbbVie &Gubra Announce License Agreement to Develop an Amylin Analog
03 Mar 2025 //
PRESS RELEASE
Gubra reveals early data for once-weekly obesity asset
13 Nov 2024 //
FIERCE BIOTECH

Market Place
Sourcing Support